TickerSpark Feed

PFE coverage

Every article, report, and earnings note where PFE appears.

Top Big Pharma Stocks: Our 5 Best Stock Picks for July 2026

Five big pharma stocks are ranked in a countdown, comparing specialty franchises, profitability, valuation, growth and earnings consistency for July 2026.

Jul 31, 2026·11 MIN

big pharma

Opinion

The GLP-1 trade is becoming a market-share war, not a rising-tide story

Investors still talk about obesity drugs like a category ETF, but the evidence now points to a leadership trade. Eli Lilly is widening the gap with stronger execution, better prescription momentum, and a more threatening pipeline just as Novo Nordisk faces pricing pressure and a weaker growth profile.

Jun 3, 2026·5 MIN

GLP-1 Healthcare Competition

OpinionMRK

Merck’s latest data may have bought it more time than bears want to admit

Merck’s patent-cliff problem is real, but the market is acting like the runway ends tomorrow when the core franchise is still expanding today. Fresh lung-cancer data, rising Keytruda sales, and a packed oncology catalyst calendar make MRK look stronger than the fear trade suggests.